Dose 1: (2.5mg)
4 weeks treatment
$375
- Injected once a week, using a insulin syringe
MEDICAL WEIGHT MANAGEMENT
Medical Weight Loss
Tirzepatide
Tirzepatide, a prescription medication used to treat Type 2 diabetes, is a GIP and GLP-1 receptor agonist also used for weight loss. It is injected under the skin once a week. Tirzepatide was FDA approved in the United States to treat Type 2 diabetes in May 2022 under the brand name “Mounjaro”. In November 2023, it was approved for weight loss under the brand name “Zepbound”.
Who is a candidate?
Adults 18 years of age or older. Individuals with a BMI of 30 or greater . Individuals with a BMI of 27 or greater, with at least one weight-related health issue
Starting Your Journey
Schedule a consultation by reaching out to us via phone or online. We will evaluate your suitability for treatment. If you meet the criteria, your provider may prescribe Tirzepatide. The dose will be increased over 4 to 20 weeks to reach target doses of 5 mg, 10 mg, or 15 mg weekly. We will monitor your progress through follow-up visits and adjust treatment if necessary.
TIRZEPATIDE PACKAGES
Confirm current pricing, package contents, and availability with your clinic. Do not use this page to choose or adjust a dose.
Dose 2: (5mg)
4 weeks treatment
$425
- Injected once a week, using a insulin syringe
Dose 3: (7.5mg)
4 weeks treatment
$475
- Injected once a week, using a insulin syringe
Dose 4: (10mg)
4 weeks treatment
$525
- Injected once a week, using a insulin syringe
Dose 5: (12.5mg)
4 weeks treatment
$575
- Injected once a week, using a insulin syringe
Dose 6: (15mg)
4 weeks treatment
$625
- Injected once a week, using a insulin syringe
Tirzepatide 3 Months Program
$1099
Dosage options range from 2.5mg to 7.5 mg per week (Total 60mg)
Book NowInformation is for educational purposes, not individual medical advice. Treatment eligibility, ingredients, and risks must be discussed with a qualified provider. Individual experiences vary.